228 related articles for article (PubMed ID: 23443351)
1. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.
Balageas P; Cornelis F; Le Bras Y; Hubrecht R; Bernhard JC; Ferrière JM; Ravaud A; Grenier N
Eur Radiol; 2013 Jul; 23(7):1925-32. PubMed ID: 23443351
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
3. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results.
Krokidis M; Spiliopoulos S; Jarzabek M; Fotiadis N; Sabharwal T; O'Brien T; Adam A
Eur Radiol; 2013 Jul; 23(7):1933-9. PubMed ID: 23475163
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal cell carcinoma tumours compared with published results of using computed tomography guidance.
Davis K; Kielar A; Jafari K
Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S23-32. PubMed ID: 21145195
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
8. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
9. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
13. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients.
Veltri A; De Fazio G; Malfitana V; Isolato G; Fontana D; Tizzani A; Gandini G
Eur Radiol; 2004 Dec; 14(12):2303-10. PubMed ID: 15599549
[TBL] [Abstract][Full Text] [Related]
15. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
[TBL] [Abstract][Full Text] [Related]
17. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma.
Kim HJ; Park BK; Chung IS
Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818
[TBL] [Abstract][Full Text] [Related]
18. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
19. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]